Stay updated with breaking news from Klingenstein Fields. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Klingenstein Fields & Co. LP lowered its stake in Merck & Co., Inc. (NYSE:MRK – Free Report) by 0.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 312,919 shares of the company’s stock after selling 2,457 shares during the quarter. […]
Klingenstein Fields & Co. LP boosted its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 6.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,743 shares of the company’s stock after purchasing an additional 500 […]
Klingenstein Fields & Co. LP trimmed its holdings in Netflix, Inc. (NASDAQ:NFLX – Free Report) by 0.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 41,212 shares of the Internet television network’s stock after selling 200 shares during the quarter. Klingenstein Fields […]
Klingenstein Fields & Co. LP increased its holdings in shares of Chubb Limited (NYSE:CB – Free Report) by 0.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 111,405 shares of the financial services provider’s stock after purchasing an additional 613 shares […]
Klingenstein Fields & Co. LP lowered its stake in Netflix, Inc. (NASDAQ:NFLX – Free Report) by 0.5% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 41,212 shares of the Internet television network’s stock after selling 200 shares during the period. Klingenstein Fields & Co. […]